Renaud Savary
Advertisement
Renaud Savary is Senior Investment Analyst, Pharmaceutical Sector, at Avem Capital.
Articles by Renaud Savary
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
The Economics of the 340B Drug Pricing Program: Strategic Imperatives for the Life Sciences Industry in 2026
2
Eli Lilly and Abbisko Announce Drug Development Collaboration
3
How 3D Printing Speeds Up Drug Production
4
Pharmaceutical Executive Daily: Eli Lilly and Abbisko Announce Drug Development Collaboration
5